Demyelinating lesions of the central nervous system (CNS) are classically known to be hypometabolic on 18 F-Flurodeoxyglucose Positron Emission Tomography ( 18 F-FDG PET). However, demyelinating lesions may show increased tracer uptake on 18 F-FDG PET and can radiologically mimic neoplasm. Delayed tracer uptake on FDG PET is one of the diagnostic hallmarks of primary CNS lymphoma (PCNSL). Here, we present two cases in which the brain lesions showed increased FDG uptake on delayed integrated PET Magnetic Resonance Imaging (MRI), which were pathologically proven as CNS demyelination. Such demyelinating lesions may also act as "sentinel lesions" and potential harbinger of PCNSL on follow-up.
Primary
demyelinating diseases of the central nervous system (CNS) include several entities such as multiple sclerosis (MS), myelinoclastic diffuse sclerosis, and acute demyelinating encephalomyelitis (ADEM). These lesions have also been synonymously termed as Tumefactive Demyelinating Lesions (TDL), demyelinating pseudotumor, tumefactive MS (TMS), tumor-like demyelinating lesions, or giant plaques in the literature. [1] Tumefactive demyelinating lesions (TDL), which can be an isolated entity or presenting feature of MS (TMS), may pose a serious diagnostic challenge for a radiologist that frequently prompts biopsy for further evaluation. [2] On 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET), demyelinating lesions generally tend to be hypometabolic. Maffione et al . [3] have demonstrated increased uptake in TMS. Hypermetabolism has also been described in TDL, primary CNS lymphoma (PCNSL), and glioma. [4] However, this uptake is significantly more for PCNSL and glioma as compared to TDL. [4] Most of the literature on FDG PET in PCNSL employs early imaging; however, Jeanguillaume et al. [5] have demonstrated the role of dual-phase 18 F-FDG PET in picking up additional lesions in PCNSL which were more conspicuous on the delayed phase. We hereby present two cases who presented with CNS lesions showing increased tracer uptake on delayed 18 F-FDG PET magnetic resonance imaging (MRI) and provisionally being diagnosed as PCNSL. However, both were pathologically proven to be CNS demyelination on subsequent biopsy from the lesions.
The first patient was a 10-year-old female child who had presented with a history of multiple episodes of vomiting followed by reduced speech output since the age of 8 years. One month before admission, she had left hemiparesis which transiently improved. She also had right lower motor neuron type of facial palsy, slurring of speech, difficulty in swallowing along with positive cerebellar signs. MRI showed multifocal confluent hyperintensities in the lateral aspect of pons, bilateral middle cerebellar peduncles, dentate nuclei, and peridentate white matter, which showed varying degrees of diffusion restriction with irregular and ring enhancement on
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For reprints contact: reprints@medknow.com postcontrast study [ Figure 1 ]. The patient underwent 18 F-FDG PET-MRI in the Siemens mMR Biograph scanner with a routine scan at 45 min (after tracer injection) and a delayed scan repeated at 270 min. The early scan showed abnormal increase in tracer uptake at the periphery of the lesions with further increase in the delayed scan [ Figure 2] . A provisional diagnosis of PCNSL was made. However, biopsy from the posterior fossa lesion showed predominant foamy histiocytes positive for CD68, admixed with few CD3-positive T-cells. There was no evidence of CD20-positive B-cells, atypical or neoplastic cells. The above-mentioned features were compatible with inflammatory demyelinating pathology. During hospital stay, there was worsening of her cerebellar signs with reduced speech output, despite on intravenous (IV) methylprednisolone.
The second patient was a 37-year-old female who presented with paresthesia of the face and decreased vision in the left eye for 4 months, which was followed by initially left and then right hemiparesis over the next 2 months. Before admission, she also had urinary incontinence and reduced speech output for 1 month. MRI showed large confluent hyperintense lesions in the bilateral cerebral hemispheres with involvement of corpus callosum splenium and posterior aspect of right basal ganglia. Peripheral diffusion restriction with incomplete "open ring enhancement" was seen in the centrum semiovale lesions. There was expansion of the spinal cord with multiple peripherally enhancing intramedullary lesions [ Figure 3 ]. This patient also underwent 18 F-FDG PET-MRI with initial and delayed scans being performed. There was abnormal increased in tracer uptake at the periphery of the lesions in the centrum semiovale and left periventricular region with the delayed scan showing significant increase in maximum standard uptake value (SUV max ) of the above-mentioned lesions [ Figure 4 ]. Similar to the first case, initially, PCNSL was diagnosed based on the PET-MRI findings. However, biopsy from the left centrum semiovale lesion showed extensive reactive changes of the glial cells admixed with numerous scattered CD68-positive foamy macrophages. There was perivascular and diffuse infiltration of parenchyma with predominant Both of these patients were provisionally diagnosed as PCNSL in view of increased FDG uptake in the delayed scan, which is one of the hallmarks to differentiate inflammatory versus neoplastic pathology. It was also interpreted as false low uptake of FDG as opposed to that normally seen in PCNSL due to drug interference (both of these patients were on IV and oral steroids).
PCNSL has a very high cellular density with increased glucose metabolism and usually show intense uptake of 18 F-FDG, SUV max being about 2.5 times higher than the average SUV in the normal gray matter. [6] TDL can be found in 2.8% of MS patients. They may also be seen in patients without preexisting MS history, although they usually develop typical MS features in the near future. [2] Delayed uptake of FDG on PET-MRI has been classically described in neoplastic etiology, including PCNSL; [5] however, both our cases with the above findings were pathologically proven to be demyelination. It should be kept in mind that PCNSL can be preceded by sentinel lesions indistinguishable from the demyelination of MS or ADEM, and steroid treatment before biopsy may obscure diagnosis of PCNSL. [7] These antecedent demyelinating "sentinel lesions" can act as a potential harbinger for the development of PCNSL in the future, although the pathogenesis remains unclear. [8] Although delayed uptake of 18 F-FDG on PET-MRI has been described in neoplastic etiology including PCNSL, the differential diagnosis of demyelination must be kept in mind as is evident in both our cases. Combination of the spectrum of clinical findings, MRI (routine and advanced sequences), and nuclear imaging is likely to pave the path in arriving at diagnosis while facing similar cases in the future.
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